Neuralink

SpaceX

Neuralink

Neuralink doesn't have a traditional revenue model yet — it's still in clinical trials. The near-term plan is medical devices sold to hospitals and clinics for treating neurological conditions.

Brain-computer interfaces for paralysis, ALS, blindness, and other conditions would be reimbursed by insurance and healthcare systems, similar to cochlear implants or deep brain stimulators.

The long-term vision is consumer neurotechnology — healthy people choosing to get brain implants for enhanced cognition, communication, or AI interaction. This is years or decades away and faces massive regulatory and ethical hurdles.

But if it works, the total addressable market is literally every human brain on the planet.

The surgical robot is potentially a separate revenue stream. Even if the implant itself doesn't dominate, the precision robotics technology developed for neural surgery could be licensed to other medical device companies.

Neuralink has also built custom chip fabrication capabilities that could have applications beyond brain interfaces.

SpaceX

SpaceX makes money three ways. First, launch services — companies and governments pay SpaceX to put their satellites into orbit.

A Falcon 9 launch costs about $67 million, which undercut the competition by 75% when it debuted. Second, Starlink — SpaceX's own satellite internet constellation, which is now generating over $6 billion in annual revenue from 4+ million subscribers.

Third, government contracts — NASA pays SpaceX to ferry astronauts to the International Space Station and the DoD pays for national security launches.

The secret sauce is reusability. Before SpaceX, every rocket was used once and thrown into the ocean.

SpaceX figured out how to land the first stage booster back on Earth and fly it again. A single Falcon 9 booster has flown over 20 times.

That's like the difference between throwing away an airplane after every flight versus keeping it for decades.

Neuralink

Elon Musk had been talking about brain-computer interfaces publicly since at least 2016. His stated motivation was existential: if AI becomes superintelligent, humans need a way to merge with it or risk becoming irrelevant.

The solution, in his mind, was a direct neural link between the human brain and computers.

Neuralink was quietly incorporated in July 2016 in California. Musk recruited a team of eight co-founders — neuroscientists, engineers, and chip designers from institutions like UC Berkeley, MIT, and Lawrence Livermore National Laboratory.

The founding team included Ben Rapoport, a neurosurgeon who understood both the medical and engineering sides, and Dongjin Seo, who had done PhD research on neural dust (tiny wireless brain sensors).

The company operated in stealth for two years before a 2019 presentation where Musk revealed the vision: a coin-sized device implanted in the skull containing thousands of ultra-thin electrode threads inserted into the brain by a custom-built surgical robot. The threads are thinner than a human hair — roughly 5 microns wide — and each one contains multiple electrodes that read neural signals.

The robot was necessary because no human surgeon could place threads that thin without damaging brain tissue.

SpaceX

In 2001, Elon Musk had just sold PayPal to eBay for $1.5 billion and was sitting on roughly $180 million after taxes. Most people would buy an island.

Musk decided to buy rockets. His original idea was even weirder — he wanted to send a small greenhouse to Mars called "Mars Oasis" to reignite public interest in space exploration.

He flew to Russia three times to buy refurbished ICBMs. The Russians kept raising the price and at one point literally spat on him.

On the flight home from that last failed Russia trip, Musk opened a spreadsheet and started calculating the raw material costs of building a rocket from scratch. He realized the materials were only about 3% of the typical price of a rocket.

The rest was markup, inefficiency, and monopoly pricing by companies like Boeing and Lockheed Martin. He decided to build his own.

SpaceX was founded in June 2002 in a warehouse in El Segundo, California. Musk put in $100 million of his own money.

He hired Tom Mueller, a legendary rocket propulsion engineer who had been building rocket engines in his garage as a hobby. The first rocket, Falcon 1, was supposed to be the cheapest orbital rocket ever built.

It took six years and three spectacular explosions before it finally worked.

Neuralink

Neuralink's growth strategy is the classic Musk playbook: start with the premium use case that justifies the cost, then scale down. Phase 1 is medical — treat severe neurological conditions where no other option exists.

Quadriplegia, ALS, locked-in syndrome. Patients who literally cannot move or speak are willing to undergo experimental brain surgery.

The FDA granted Breakthrough Device designation in 2020, and the first human trial (PRIME study) began in 2024.

Phase 2 is expanding medical indications — blindness, depression, epilepsy, Parkinson's. Each new condition multiplies the patient population and the regulatory pathway, building clinical evidence along the way.

Phase 3 — the moonshot — is consumer enhancement. Musk has described this as "conceptual telepathy," where you think a message and it sends.

This phase requires proving extraordinary safety over years of medical use first. Nobody is going to electively implant a brain chip unless the medical version has been proven safe for a decade.

SpaceX

SpaceX's growth strategy was simple: be cheaper than everyone, then be better than everyone, then be the only option.

They started by undercutting the launch market. The United Launch Alliance (Boeing + Lockheed Martin joint venture) was charging $300-400 million per launch.

SpaceX offered $67 million. Government agencies and commercial satellite companies started lining up.

Reusability was the real game-changer. Landing a rocket booster looked like science fiction when SpaceX first attempted it in 2013.

They failed over and over — spectacular ocean landings, explosions on drone ships, near-misses. But in December 2015, a Falcon 9 first stage landed back at Cape Canaveral.

It was the first time an orbital-class rocket had ever landed after a mission. Now they do it routinely — it's almost boring.

Starlink created a completely new revenue stream. Instead of just launching other people's satellites, SpaceX launched thousands of its own.

By 2024, Starlink had over 4 million subscribers and was generating billions in revenue. It turned SpaceX from a launch company into a telecom company.

Neuralink

The FDA and regulatory approval process is the primary bottleneck. Brain implants are Class III medical devices — the highest risk category.

Every design change, every new indication, requires extensive clinical data. The USDA also investigated Neuralink in 2022 for potential animal welfare violations in their primate testing program, which created PR headaches.

Long-term biocompatibility is an unsolved problem. The brain treats any foreign object as an invader and forms scar tissue around it, which can degrade signal quality over time.

Making an implant that works reliably for decades inside a hostile biological environment is one of the hardest engineering problems in medicine. Neuralink's thread retraction issue in their first human patient — where some threads pulled away from the brain — highlighted how much work remains.

Talent retention has been rocky. Max Hodak, the original president, left in 2021.

Several founding scientists departed. Working for Musk is notoriously demanding, and the timeline pressure on a medical device company clashes with the inherent need for cautious, methodical development.

SpaceX

The early days nearly killed the company. SpaceX's first three Falcon 1 launches all failed.

The first one in 2006 crashed 25 seconds after liftoff due to a corroded fuel line nut. The second in 2007 reached space but the second stage shut down early.

The third in 2008 failed because the first and second stages collided during separation. Musk had enough money for one more attempt.

If flight four failed, SpaceX was dead.

Flight four worked. On September 28, 2008, Falcon 1 became the first privately developed liquid-fuel rocket to reach orbit.

Musk has said he was so stressed during that period he was throwing up regularly.

The financial pressure was existential. Musk was simultaneously funding Tesla, which was also on the brink of bankruptcy in 2008.

He had to split his last $40 million between the two companies. He borrowed money for rent.

But right at the end of 2008, NASA awarded SpaceX a $1.6 billion contract to resupply the International Space Station. That contract saved the company.

Starship development has been its own saga. The rocket has exploded multiple times during testing.

Each failure costs hundreds of millions. But SpaceX treats failures as data — they move faster by blowing things up and iterating than competitors do by being cautious.

Neuralink

The N1 Implant — a coin-sized device (23mm diameter, 8mm thick) implanted flush with the skull containing a custom chip that wirelessly transmits neural data to external devices via Bluetooth. The R1 Robot — a precision surgical system that inserts 1,024 electrode threads into the brain with micron-level accuracy, avoiding blood vessels using computer vision.

The N1 User App — software that translates neural signals into computer commands, allowing users to control cursors, keyboards, and eventually robotic limbs through thought alone. BCI Software Platform — the signal processing and machine learning stack that decodes raw brain signals into intended actions.

SpaceX

Falcon 9 is the workhorse — the most-launched rocket in the world. It carries satellites to orbit and astronauts to the ISS, and the first stage lands itself for reuse.

Falcon Heavy is three Falcon 9 boosters strapped together — the most powerful operational rocket in the world until Starship came along. Dragon is the spacecraft that carries astronauts and cargo to the ISS.

It's the only American vehicle currently flying humans to space. Starlink is the satellite internet service — over 6,000 satellites in orbit delivering broadband to 100+ countries.

Starship is the big one — the tallest and most powerful rocket ever built, designed to carry 100+ people to Mars. It's still in testing but has already completed a full flight.

Neuralink

Elon Musk has been the primary funder, investing hundreds of millions of his personal wealth. The company raised $205 million in a Series C in 2021, then $280 million in a Series D in 2023 led by Founders Fund (Peter Thiel's firm).

A 2024 round reportedly valued the company at $8.9 billion. Google Ventures (GV) and DFJ Growth have also participated.

The investor base is narrow compared to most startups at this valuation.

SpaceX

Founders Fund, Draper Fisher Jurvetson, Google, Fidelity Investments, Valor Equity Partners, Baillie Gifford, a]6z (Andreessen Horowitz), NASA (as customer/partner)